Brawn Biotech Ltd — Insider Trading, 27-12-2025: Insider Trading / SAST

Brawn Biotech has closed its trading window for designated persons and their immediate relatives, effective January 1, 2026. This window will reopen 48 hours after the company declares the financial results for the quarter ended December 31, 2025. Insiders are advised against trading company securities during this period. The date for the board meeting to approve these results will be announced separately. This move prevents insider trading and maintains transparency around upcoming earnings for shareholders.